Investigators assessed shear wave elastography (SWE) in detecting subclinical renal damage in patients with LN currently in clinical remission.

In this retrospective study, researchers sought to determine the efficacy, safety, and effectiveness of a reduced ARSI dose compared to a full dose in non-metastatic castration-resistant prostate ...

Increase from 0.16 to 0.44 new monthly dispensations per 1,000 people reported between January 2016 and June 2024. (HealthDay News) — During the COVID-19 pandemic, rates of new stimulant prescriptions ...

Policy implementation linked to increase of 5.3 transplants per 1,000 listings in interrupted time series analysis. (HealthDay News) — Implementation of an Organ Procurement and Transplantation ...

More patients receiving obinutuzumab versus placebo had primary end point of SLE Responder Index 4. (HealthDay News) — For patients with systemic lupus erythematosus (SLE), obinutuzumab, a ...

(HealthDay News) — Poor childhood oral health is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD) in adulthood, according to a study published in the April 1 issue ...

In this phase 2 study, researchers aimed to evaluate the effectiveness of tyrosine kinase inhibition in relapsed or refractory germ cell tumors.

Patients with lupus nephritis complicated by thrombotic microangiopathy tend to have high death risk and poor renal outcomes. They need vital and effective therapies.

Contemporary donation after circulatory death donors are more medically complex than those from prior eras.

No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs.

Authors say individuals with COVID-19, particularly those at high risk for kidney disease, may need additional monitoring of kidney function.

Prasad's stint included several controversial vaccine decisions; the FDA is now searching for a new head for its vaccine division.